GAMMA Investing LLC increased its stake in Amdocs Limited (NASDAQ:DOX – Free Report) by 115.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 800 shares of the technology company’s stock after purchasing an additional 428 shares during the period. GAMMA Investing LLC’s holdings in Amdocs were worth $70,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also bought and sold shares of DOX. Norwood Financial Corp bought a new position in shares of Amdocs in the 1st quarter worth $33,000. Central Pacific Bank Trust Division bought a new position in Amdocs in the first quarter valued at $53,000. Riverview Trust Co purchased a new stake in Amdocs during the first quarter valued at about $55,000. American National Bank bought a new stake in Amdocs during the second quarter worth about $76,000. Finally, Blue Trust Inc. boosted its holdings in shares of Amdocs by 18.0% in the 2nd quarter. Blue Trust Inc. now owns 1,138 shares of the technology company’s stock worth $90,000 after purchasing an additional 174 shares in the last quarter. 92.02% of the stock is owned by hedge funds and other institutional investors.
Amdocs Trading Down 0.5 %
NASDAQ:DOX opened at $88.73 on Wednesday. Amdocs Limited has a 12 month low of $74.41 and a 12 month high of $94.04. The company has a current ratio of 1.24, a quick ratio of 1.24 and a debt-to-equity ratio of 0.21. The company has a 50-day moving average price of $85.96 and a 200-day moving average price of $83.48. The stock has a market cap of $10.43 billion, a price-to-earnings ratio of 19.94, a P/E/G ratio of 1.42 and a beta of 0.74.
Amdocs Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be issued a dividend of $0.479 per share. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.16%. The ex-dividend date of this dividend is Monday, September 30th. Amdocs’s dividend payout ratio (DPR) is presently 42.92%.
Wall Street Analyst Weigh In
DOX has been the topic of a number of research reports. StockNews.com raised Amdocs from a “buy” rating to a “strong-buy” rating in a report on Thursday, October 10th. Stifel Nicolaus started coverage on shares of Amdocs in a report on Wednesday, October 2nd. They set a “buy” rating and a $100.00 price target for the company. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $102.00.
About Amdocs
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Further Reading
- Five stocks we like better than Amdocs
- What Are Dividend Champions? How to Invest in the Champions
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- Election Stocks: How Elections Affect the Stock Market
- AMD Gains Momentum With AI: Can It Beat Expectations?
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX – Free Report).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.